ITGAM
Basic information
Region (hg38): 16:31259967-31332892
Previous symbols: [ "CR3A", "CD11B" ]
Links
Phenotypes
GenCC
Source:
- systemic lupus erythematosus (Supportive), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGAM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 157 | 168 | ||||
missense | 406 | 19 | 10 | 435 | ||
nonsense | 10 | 13 | ||||
start loss | 0 | |||||
frameshift | 12 | 12 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 26 | 45 | 1 | 72 | ||
non coding | 11 | 126 | 10 | 147 | ||
Total | 0 | 0 | 452 | 305 | 29 |
Variants in ITGAM
This is a list of pathogenic ClinVar variants found in the ITGAM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-31260068-G-T | Uncertain significance (Jan 06, 2024) | |||
16-31260071-C-T | Uncertain significance (Oct 26, 2023) | |||
16-31260072-T-G | Uncertain significance (Jul 21, 2024) | |||
16-31260078-T-C | Uncertain significance (Nov 23, 2021) | |||
16-31260079-C-G | Likely benign (Nov 11, 2023) | |||
16-31260097-A-C | Uncertain significance (May 27, 2024) | |||
16-31260099-G-A | Likely benign (Nov 08, 2022) | |||
16-31260105-G-C | Likely benign (Apr 14, 2021) | |||
16-31260106-G-GCAC | Likely benign (Sep 27, 2022) | |||
16-31260109-T-A | Likely benign (Jan 26, 2024) | |||
16-31261679-A-C | Likely benign (May 13, 2024) | |||
16-31261686-C-T | Likely benign (Jan 07, 2025) | |||
16-31261693-C-T | Likely benign (Mar 18, 2024) | |||
16-31261718-T-C | Likely benign (Oct 24, 2024) | |||
16-31261721-G-A | Uncertain significance (Jun 15, 2022) | |||
16-31261722-A-G | Uncertain significance (Dec 24, 2023) | |||
16-31261725-C-T | Uncertain significance (Oct 22, 2023) | |||
16-31261732-C-T | Likely benign (Oct 13, 2023) | |||
16-31261753-C-T | Likely benign (Dec 30, 2023) | |||
16-31261754-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
16-31261759-G-A | Likely benign (Feb 10, 2022) | |||
16-31261761-G-A | Uncertain significance (Aug 28, 2024) | |||
16-31261765-C-T | Likely benign (Oct 23, 2024) | |||
16-31261766-G-A | Uncertain significance (Jul 11, 2022) | |||
16-31261774-C-T | Likely benign (Aug 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGAM | protein_coding | protein_coding | ENST00000544665 | 30 | 72903 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.31e-11 | 1.00 | 125406 | 0 | 152 | 125558 | 0.000605 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.42 | 582 | 687 | 0.847 | 0.0000410 | 7488 |
Missense in Polyphen | 207 | 273.92 | 0.75568 | 3135 | ||
Synonymous | 1.04 | 262 | 284 | 0.922 | 0.0000179 | 2287 |
Loss of Function | 3.87 | 28 | 60.5 | 0.463 | 0.00000305 | 677 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000642 | 0.000610 |
Ashkenazi Jewish | 0.00427 | 0.00408 |
East Asian | 0.000398 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000635 | 0.000625 |
Middle Eastern | 0.000398 | 0.000381 |
South Asian | 0.000566 | 0.000555 |
Other | 0.000501 | 0.000491 |
dbNSFP
Source:
- Function
- FUNCTION: Integrin ITGAM/ITGB2 is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is identical with CR-3, the receptor for the iC3b fragment of the third complement component. It probably recognizes the R-G-D peptide in C3b. Integrin ITGAM/ITGB2 is also a receptor for fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides of fibrinogen gamma chain. Regulates neutrophil migration (PubMed:28807980). In association with beta subunit ITGB2/CD18, required for CD177-PRTN3-mediated activation of TNF primed neutrophils (PubMed:21193407). May regulate phagocytosis-induced apoptosis in extravasated neutrophils (By similarity). May play a role in mast cell development (By similarity). {ECO:0000250|UniProtKB:P05555, ECO:0000269|PubMed:21193407, ECO:0000269|PubMed:28807980, ECO:0000305}.;
- Disease
- DISEASE: Systemic lupus erythematosus 6 (SLEB6) [MIM:609939]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:18204446, ECO:0000269|PubMed:18204448}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);Pertussis - Homo sapiens (human);Legionellosis - Homo sapiens (human);Acute myeloid leukemia - Homo sapiens (human);Phagosome - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Staphylococcus aureus infection - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Leishmaniasis - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Integrin-mediated Cell Adhesion;Vitamin D Receptor Pathway;Focal Adhesion;Microglia Pathogen Phagocytosis Pathway;TYROBP Causal Network;Interleukin-4 and 13 signaling;Fibrin Complement Receptor 3 Signaling Pathway;Neutrophil degranulation;Integrin cell surface interactions;Toll-Like Receptors Cascades;Extracellular matrix organization;Innate Immune System;Immune System;Integrin;Cell surface interactions at the vascular wall;Hemostasis;Toll Like Receptor 4 (TLR4) Cascade;amb2 Integrin signaling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling;Beta2 integrin cell surface interactions
(Consensus)
Intolerance Scores
- loftool
- 0.543
- rvis_EVS
- -0.59
- rvis_percentile_EVS
- 18.28
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- N
- hipred_score
- 0.474
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.562
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Itgam
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- microglial cell activation;phagocytosis, engulfment;cell adhesion;integrin-mediated signaling pathway;ectodermal cell differentiation;cytokine-mediated signaling pathway;extracellular matrix organization;positive regulation of superoxide anion generation;toll-like receptor 4 signaling pathway;neutrophil degranulation;positive regulation of neutrophil degranulation;innate immune response;negative regulation of dopamine metabolic process;leukocyte migration;positive regulation of phagocytosis, engulfment;positive regulation of protein targeting to membrane;amyloid-beta clearance;cell-cell adhesion via plasma-membrane adhesion molecules;complement-mediated synapse pruning;vertebrate eye-specific patterning;positive regulation of neuron death;positive regulation of microglial cell activation;cell surface receptor signaling pathway involved in cell-cell signaling;positive regulation of prostaglandin-E synthase activity
- Cellular component
- extracellular space;plasma membrane;integrin complex;external side of plasma membrane;cell surface;integrin alphaM-beta2 complex;specific granule membrane;plasma membrane raft;extracellular exosome;tertiary granule membrane
- Molecular function
- amyloid-beta binding;complement component C3b binding;protein binding;heat shock protein binding;metal ion binding;protein heterodimerization activity